{"id":"https://openalex.org/W2891843249","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e21014","title":"The Mayo Clinic experience in patients with metastatic melanoma who have failed previous pembrolizumab treatment.","display_name":"The Mayo Clinic experience in patients with metastatic melanoma who have failed previous pembrolizumab treatment.","publication_year":2016,"publication_date":"2016-05-20","ids":{"openalex":"https://openalex.org/W2891843249","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e21014","mag":"2891843249"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2016.34.15_suppl.e21014","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e21014","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.e21014","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049488255","display_name":"Yiyi Yan","orcid":"https://orcid.org/0000-0001-8981-4702","observed_orcids":["https://orcid.org/0000-0001-8981-4702"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yiyi Yan","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069748645","display_name":"Jarrett J. Failing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jarrett Failing","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085479273","display_name":"Alexey A. Leontovich","orcid":"https://orcid.org/0009-0002-2014-8996","observed_orcids":["https://orcid.org/0009-0002-2014-8996"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexey A Leontovich","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000164383","display_name":"Matthew Stephen Block","orcid":"https://orcid.org/0000-0001-5692-4219","observed_orcids":["https://orcid.org/0000-0001-5692-4219"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Stephen Block","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006194799","display_name":"Robert R. McWilliams","orcid":"https://orcid.org/0000-0002-8199-5040","observed_orcids":["https://orcid.org/0000-0002-8199-5040"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert R. McWilliams","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067707171","display_name":"Lisa A. Kottschade","orcid":"https://orcid.org/0000-0001-8922-2619","observed_orcids":["https://orcid.org/0000-0001-8922-2619"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa A. Kottschade","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027176998","display_name":"Roxana Stefania Dronca","orcid":"https://orcid.org/0000-0002-5345-2268","observed_orcids":["https://orcid.org/0000-0002-5345-2268"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roxana Stefania Dronca","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082719040","display_name":"Svetomir N. Markovic","orcid":"https://orcid.org/0000-0002-9238-4325","observed_orcids":["https://orcid.org/0000-0002-9238-4325"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Svetomir Markovic","raw_affiliation_strings":["Mayo Clinic, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"15_suppl","first_page":"e21014","last_page":"e21014"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.011699999682605267,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.008100000210106373,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9900000095367432},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8690000176429749},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.8180000185966492},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.8080000281333923},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.9810000061988831},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.8730000257492065},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7799999713897705},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.9210000038146973},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.9150000214576721},{"id":"https://openalex.org/keywords/recist","display_name":"RECIST","score":0.7609999775886536}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.9641814827919006},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9632014036178589},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.8056821823120117},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.7002382278442383},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5971993803977966},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5439879298210144},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5214842557907104},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5082011222839355},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.4728572368621826},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.471225380897522},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4379033148288727},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4173825681209564},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.3928678631782532},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29454243183135986},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2016.34.15_suppl.e21014","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e21014","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.e21014","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2937754923","https://openalex.org/W2947783158","https://openalex.org/W4403285701","https://openalex.org/W4410240423","https://openalex.org/W2890823934","https://openalex.org/W2891016405","https://openalex.org/W2951285627","https://openalex.org/W4231805749","https://openalex.org/W2992569624","https://openalex.org/W2885608817"],"abstract_inverted_index":{"e21014":[0],"Background:":[1],"Blockade":[2],"of":[3,12,24,48,50,143,165,174,182,199,206,227,233,243,277],"programmed":[4],"death":[5],"(PD-1)":[6],"receptor":[7],"has":[8],"shown":[9],"unprecedented":[10],"rates":[11,102],"durable":[13],"clinical":[14,52,96,272],"responses":[15],"in":[16,40,135,220],"patients":[17,25,63,84,115,139,148,156,187,209,236],"with":[18,64,68,157,171,192,196,222,224,240,250,281],"metastatic":[19,65,251],"melanoma.":[20],"However,":[21],"the":[22,38,46,51,113,207,234],"majority":[23],"eventually":[26],"progress":[27],"on":[28],"anti-PD-1":[29],"therapy.":[30],"Currently,":[31],"there":[32],"is":[33,285],"no":[34],"standard":[35],"strategy":[36],"guiding":[37],"treatment":[39,88,217],"this":[41],"setting,":[42],"partly":[43],"due":[44],"to":[45,90,104,259],"lack":[47],"knowledge":[49],"course":[53],"after":[54,107],"PD-1":[55,279],"blockade":[56,280],"failure.":[57],"Methods:":[58],"We":[59],"retrospectively":[60],"reviewed":[61],"140":[62],"melanoma":[66,252],"treated":[67],"pembrolizumab":[69,87,108,118,256],"at":[70],"Mayo":[71],"Clinic,":[72],"Rochester,":[73],"between":[74],"January":[75],"1,":[76,80],"2012":[77],"and":[78,98,132,176,201,229,245,289],"November":[79],"2015,":[81],"identifying":[82],"70":[83,114],"who":[85,116,253],"failed":[86,117,254],"(due":[89],"disease":[91,179],"progression":[92],"or":[93,215,219],"toxicity).":[94],"The":[95,274],"outcomes":[97],"RECIST":[99],"objective":[100],"response":[101],"(ORR)":[103],"treatments":[105,152],"received":[106,121,140,149,161,167,188,210,237],"were":[109,133],"assessed.":[110],"Results:":[111],"Of":[112,125],"therapy,":[119,163],"48":[120],"further":[122,262,291],"systemic":[123,263],"therapies.":[124],"these,":[126],"43":[127,208,235],"had":[128],"complete":[129],"follow-up":[130],"data":[131],"included":[134],"our":[136],"analysis.":[137],"Thirty":[138],"1":[141],"line":[142],"subsequent":[144,151],"therapy;":[145],"while":[146],"13":[147],"multiple":[150],"(average":[153],"2.5).":[154],"Eighteen":[155],"a":[158],"BRAF":[159,185],"mutation":[160],"targeted":[162,168,189],"9":[164],"whom":[166],"therapy":[169,190,257,283],"alone,":[170],"an":[172,197,225,241],"ORR":[173,198,226,242],"55.6%":[175],"0%":[177,246],"stable":[178],"(SD).":[180],"Nine":[181],"these":[183],"18":[184],"mutant":[186],"combined":[191],"chemotherapy":[193,238],"and/or":[194,213],"immunotherapy,":[195],"22.2%":[200],"33.3%":[202],"SD.":[203,231,247],"Twenty":[204],"two":[205],"immunotherapy":[211],"(nivolumab":[212],"ipilimumab":[214],"pembrolizumab)-based":[216],"(alone":[218],"combination":[221],"chemotherapy),":[223],"31.8%,":[228],"13.6%":[230],"Nineteen":[232],"alone":[239],"26.3%":[244],"Conclusions:":[248],"Patients":[249],"previous":[255],"appear":[258],"benefit":[260],"from":[261],"treatments,":[264],"including":[265],"additional":[266],"immunotherapy.":[267],"Combination":[268],"therapies":[269],"show":[270],"favorable":[271],"outcomes.":[273,294],"biological":[275],"mechanism":[276],"combining":[278],"other":[282],"modalities":[284],"currently":[286],"being":[287],"studied":[288],"will":[290],"improve":[292],"patient":[293]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":3}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2018-09-27T00:00:00"}